Novartis to acquire Avidity Biosciences for about $12 billion – Reuters

Business News

  1. Novartis to acquire Avidity Biosciences for about $12 billion  Reuters
  2. Novartis to buy U.S. biotech firm Avidity Biosciences for about $12 billion in cash  CNBC
  3. Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline  Novartis
  4. Novartis Said to Near at Least $70-Per-Share Deal for Avidity  Bloomberg.com
  5. Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports  Reuters

Source: Business News

/by